BioNexus Gene Lab Corp (NASDAQ: BGLC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BIONEXUS GENE LAB CORP

BioNexus Gene Lab Corp (NASDAQ: BGLC)
Listen to this Section


$2.14
-0.1550 ( -6.75% ) 3.8K

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Market Data


Open $2.14
Previous Close $2.30
Volume 3.8K
Market Cap $5.51M
Day Range $2.14 - $2.31
52 Week Range $1.92 - $15.60
Shares Outstanding 2.42M
Change % -6.75%
Net Change ▼ -0.1550
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2020
CountryMalaysia
UnderwriterNetwork 1 Financial Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
nt Quarterly Reports 1 Mar 31, 2026
8-k 8K-related 14 Mar 17, 2026
8-k 8K-related 15 Feb 23, 2026
8-k 8K-related 15 Feb 03, 2026
8-k 8K-related 14 Dec 30, 2025
8-k 8K-related 14 Dec 23, 2025
def Proxies and info statements 1 Dec 03, 2025
8-k 8K-related 18 Dec 02, 2025
pre Proxies and info statements 1 Nov 14, 2025
10-q Quarterly Reports 79 Nov 14, 2025

Latest News


× Before browsing our site, please accept our cookies policy